• OPEN AN ACCOUNT
Indian Indices
Nifty
25,005.50 32.40
(0.13%)
Sensex
81,548.73 123.58
( 0.15%)
Bank Nifty
54,669.60 133.60
( 0.24%)
Nifty IT
36,003.50 -180.30
( -0.50%)
Global Indices
Nasdaq
45,515.85 -216.50
(-0.47%)
Dow Jones
6,553.33 19.72
(0.30%)
Hang Seng
44,333.89 496.22
(1.13%)
Nikkei 225
9,225.39 -17.14
(-0.19%)
Forex
USD-INR
88.14 0.12
(0.13%)
EUR-INR
103.49 0.19
(0.18%)
GBP-INR
119.43 0.38
(0.32%)
JPY-INR
0.60 0.00
(0.58%)

EQUITY - MARKET SCREENER

Vivanza Biosciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
530057
INE984E01035
1.005
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
8.12
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

milestone global ltd
Radhe Developers (India) reports standalone net profit of Rs 2.26 crore in the March 2025 quarter
May 24,2025
Net profit of Radhe Developers (India) reported to Rs 2.26 crore in the quarter ended March 2025 as against net loss of Rs 0.99 crore during the previous quarter ended March 2024. Sales declined 2.33% to Rs 4.19 crore in the quarter ended March 2025 as against Rs 4.29 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 1.35 crore in the year ended March 2025 as against net loss of Rs 4.63 crore during the previous year ended March 2024. Sales rose 13.31% to Rs 7.66 crore in the year ended March 2025 as against Rs 6.76 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales4.194.29 -2 7.666.76 13
OPM %68.97-5.83 -41.51-43.34 -
PBDT2.44-0.61 LP 2.20-3.58 LP
PBT2.25-0.81 LP 1.46-4.55 LP
NP2.26-0.99 LP 1.35-4.63 LP